Frontlight ResearchEarly access
Idiopathic pulmonary fibrosis trials in Hungary
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Phase IIb Study to Evaluate AZD8965 in Participants with Idiopathic Pulmonary Fibrosis (IPF)
- Where
- Budapest Viii, Budapest XII, Debrecen, Törökbálint
- Age
- 18 years and over
- People
- 139 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-525016-41-00 - Phase 3Not yet taking people in HungaryLong-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
- Where
- Budapest Viii, Győr
- Age
- 18 years and over
- People
- 2,380 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00 - Phase 2Taking peopleA Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Where
- Budapest, Debrecen, Törökbálint
- Age
- 40 years and over
- People
- 359 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07652658 - Phase 3Active, not recruitingA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
- Where
- Budapest Viii, Győr
- Age
- 18 years and over
- People
- 239 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503697-21-01 - Phase 3Active, not recruitingA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
- Where
- Budapest Viii, Győr
- Age
- 18 years and over
- People
- 249 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503699-25-00 - Phase 2Taking peopleStudy of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
- Where
- Budapest Viii, Budapest XII, Debrecen
- Age
- 40 years and over
- People
- 165 worldwide
- Run by
- AbbVie
See details and how to joinNCT07230288 · EU 2024-518013-25-00 - No phaseNot yet taking people in HungaryPRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- Where
- Budapest
- Age
- 18 years to 80 years
- People
- 500 worldwide
- Run by
- University of Massachusetts, Worcester
See details and how to joinNCT06855329